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OBJECTIVES The purpose of this study was to: 1) determine the significance and magnitude of associations
between novel cardiovascular disease (CVD) risk factors and peripheral arterial disease (PAD)
after adjustment for traditional risk factors; and 2) ascertain the extent to which novel risk
factors explain the excess or lower risk for PAD in different ethnic groups.
BACKGROUND Previous reports have found a significant difference in the risk of PAD by ethnic group, with
some of the risk difference attributed to different levels of traditional CVD risk factors.
METHODS A total of 6,814 individuals free of clinically apparent CVD were enrolled in the MESA
(Multiethnic Study of Atherosclerosis) and underwent standardized testing for the presence
of PAD by the ankle-brachial index. These subjects also had fasting blood drawn for serum
cholesterol, glucose, and a number of novel biomarkers for CVD. Non-Hispanic whites were
the largest ethnic group (38%), followed by African Americans (28%), Hispanics (22%), and
Chinese (12%).
RESULTS In this cross-sectional analysis, 6,653 subjects with an ankle brachial index 1.40 were
analyzed. The mean (SD) age was 62.2 (10.2) years, and 52.9% were women. Interleukin-6,
fibrinogen, D-dimer, and homocysteine were significantly associated with PAD after
adjustment for traditional CVD risk factors. Compared with non-Hispanic whites and after
adjustment for traditional and “novel” risk factors, the odds for PAD were 1.47 (95%
confidence interval [CI]: 1.07 to 2.02) times higher in African Americans, while being 0.45
(95% CI: 0.29 to 0.70) and 0.44 (95% CI: 0.24 to 0.78) in Hispanics and Chinese,
respectively.
CONCLUSIONS Ethnic associations with PAD remained significant even after adjustment for traditional and
novel risk factors. This suggests that unknown factors may account for the residual ethnic
differences in PAD. (J Am Coll Cardiol 2006;48:1190–7) © 2006 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.049of Cardiology Foundation
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rn ankle brachial index (ABI) 0.90 is considered abnor-
al and has been validated as a sensitive and highly specific
arker for lower extremity atherosclerotic occlusive disease
1,2). Typically, a peripheral artery in the legs must have a
ross-sectional area reduction 50% to produce a pressure
rop (distal to the obstruction) sufficient to result in an
bnormal ABI (3). Despite this significant atherosclerotic
isease, most persons with peripheral arterial disease (PAD)
o not have the classic symptom of ischemic exercise pain in
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hrough N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and
lood Institute. A full list of participating MESA investigators and institutions can
e found at http://www.mesa-nhlbi.org. Charles H. Hennekens, MD, served as guest
ditor for this report.d
Manuscript received February 6, 2006; revised manuscript received May 3, 2006,
ccepted May 9, 2006.he leg (“intermittent claudication”) (4–6). Thus, the ABI is
more accurate tool for detecting PAD than symptoms.
Previous studies have indicated an increase in PAD
revalence with age and usually, although not uniformly,
ore disease in men than women (4,7,8). Several studies
ave indicated a higher prevalence in African Americans
ompared with non-Hispanic whites (7–12). Notably, 3
tudies have reported ethnic-specific PAD rates in more
han 2 groups (7,11,12). Using data from the National
ealth and Nutrition Examination Survey (NHANES)
999 to 2000, Selvin et al. (7) reported higher prevalence
ates in African Americans and Mexican Americans com-
ared with non-Hispanic whites. Similarly, in a study of
mployees and retirees from a large public university in
alifornia, compared with non-Hispanic whites, PAD rates
ere higher in African Americans, similar in Hispanics, and
omewhat lower in Asians. Importantly, the differences in
frican Americans were only partially attributable to higher
ates of diabetes and hypertension (12).
Several studies have indicated that cigarette smoking and
iabetes are the 2 strongest risk factors for PAD (7,8,13).
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September 19, 2006:1190–7 Ethnicity as a Risk Factor for PADlso important are hypertension and the combination of
ow high-density lipoprotein (HDL) cholesterol and ele-
ated triglycerides (7,14–16). Conversely, low-density li-
oprotein (LDL) cholesterol has not been shown to be a
onsistent risk factor for PAD (13). Whether these risk factors
how the same relationships to PAD in both genders and
cross age and ethnic groups is currently unknown. Addition-
lly, some studies have reported links between newer (“novel”)
ardiovascular risk markers and PAD. Specifically, homocys-
eine, C-reactive protein, interleukin-6, fibrinogen, D-dimer,
nd plasmin-antiplasmin complex have been reported to be
inked to PAD (17–22), whereas infectious markers such as
hlamydia pneumoniae serology have received little
ttention.
Whether these new risk markers can explain a substantial
mount of the ethnic differences in PAD prevalence, after
djustment for traditional cardiovascular risk factors, re-
ains unanswered. Therefore, the aims of this study were
o: 1) determine the significance and magnitude of associ-
tions between novel cardiovascular disease (CVD) risk
actors and PAD after adjustment for traditional risk fac-
ors; and 2) ascertain the extent to which novel risk factors
xplain the excess or lower risk for PAD in different ethnic
roups. We hypothesize that ethnic-specific differences in
AD prevalence will be partially, but not entirely, explained
y novel risk factors.
ETHODS
ubjects. Details about the study design for the MESA
Multi-Ethnic Study of Atherosclerosis) have been pub-
ished elsewhere (23). In brief, between July 2000 and
ugust 2002, 6,814 men and women who identified them-
elves as white, African American, Hispanic, or Chinese,
ere 45 to 84 years old, and were free of clinically apparent
VD were recruited from portions of 6 U.S. communities:
altimore City and Baltimore County, Maryland; Chicago,
Abbreviations and Acronyms
ABI  ankle brachial index
AUC  area under the curve
BMI  body mass index
CHD  coronary heart disease
CI  confidence interval
CVD  cardiovascular disease
DP  dorsalis pedis
HDL  high-density lipoprotein
LDL  low-density lipoprotein
MESA  Multi-Ethnic Study of Atherosclerosis
NHANES  National Health and Nutrition
Examination Survey
OR  odds ratio
PAD  peripheral arterial disease
PT  posterior tibial
ROC  receiver-operator characteristic
SBP  systolic blood pressurellinois; Forsyth County, North Carolina; Los Angeles aounty, California; Northern Manhattan and the Bronx,
ew York; and St. Paul, Minnesota. Each field site re-
ruited from locally available sources, which included lists of
esidents, lists of dwellings, and telephone exchanges. In the
ast few months of the recruitment period, supplemental
ources (lists of Medicare beneficiaries from the Centers for
edicare and Medicaid Services and referrals by partici-
ants) were used to ensure adequate numbers of minorities
nd elderly subjects. Individuals with a history of physician-
iagnosed heart attack, angina, heart failure, stroke, or
ransient ischemic attack, or having undergone an invasive
rocedure for CVD (coronary artery bypass grafting, angio-
lasty, valve replacement, or pacemaker placement) were
xcluded from participation. The institutional review boards
t all participating centers approved the study, and all
articipants gave informed consent.
ata collection. Standardized questionnaires were used to
btain demographic and information about level of educa-
ion, annual household income, smoking history, and med-
cation usage for high blood pressure, high cholesterol, or
iabetes. Cigarette smoking was defined as current, former,
r never. Height and weight were measured with partici-
ants wearing light clothing and no shoes. Body mass index
BMI) was calculated as weight in kilograms divided by
eight in meters squared. Resting blood pressure was
easured 3 times in seated participants with a Dinamap
odel Pro 100 automated oscillometric sphygmomanome-
er (Critikon, Wipro GE Healthcare, Waukesha, Wiscon-
in). The average of the last 2 measurements was used in
nalysis. Hypertension was defined as systolic pressure
140 mm Hg, diastolic pressure 90 mm Hg, or current
se of antihypertensive medication.
aboratory. Blood was collected and stored at 70°F until
eeded for the appropriate assays. Total and HDL choles-
erol, triglycerides, and glucose levels were measured from
lood samples obtained after a 12-h fast; LDL cholesterol
as calculated with the Friedewald equation (24). The total
holesterol/HDL cholesterol ratio was considered abnormal
f it was5.0 or if the participant used medication to reduce
holesterol (“dyslipidemia”). Diabetes was defined as fasting
lucose 126 mg/dl or use of hypoglycemic medication.
mpaired fasting glucose was defined as fasting glucose 100
o 125 mg/dl (25).
In addition to the previously listed indexes, fasting blood
as collected for the following categories of analytes:
ipids, systemic inflammation (high-sensitivity C-reactive
rotein, fibrinogen, interleukin-6), insulin concentration
fasting insulin), infectious agents (C. pneumoniae antibody
iter), hemostasis/fibrinolysis (factor VIII, plasmin-
ntiplasmin complex, D-dimer), as well as homocysteine
nd von Willebrand factor. Of note, von Willebrand factor
as collected in a random sample of 1,000 subjects instead
f the entire cohort.
BI protocol. After the participant rested supine for 5
in, systolic blood pressure (SBP) was measured in both
rms with the appropriate-sized arm cuff. For each leg, the
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Ethnicity as a Risk Factor for PAD September 19, 2006:1190–7BP in each posterior tibial (PT) and dorsalis pedis (DP)
rtery was measured. All pressures were detected with a
ontinuous-wave Doppler ultrasound probe. The leg-
pecific ABI was calculated as the higher SBP in the PT or
P divided by the higher of the 2 arm SBPs. The highest
rm SBP was used because of the strong association between
AD and subclavian stenosis (26). For each subject, PAD
as defined by an ABI 0.90 in either leg.
tatistical analysis. This was a cross-sectional analysis of
ata collected at the baseline visit. Chi-square tests were
sed to assess unadjusted associations between the presence
f PAD and ethnicity. Logistic regression models were used
o assess adjusted associations. In each model, the following
raditional cardiovascular risk factors were forced into the
odel in addition to ethnicity: age, gender, BMI, diabetes,
urrent smoking, hypertension, and HDL and LDL cho-
esterol. To assess whether the newer risk factors explained
ome of the ethnic differences, we forced these into the
odel including the traditional risk factors, and examined
he changes in the ethnicity odds ratios (OR), significance,
nd the area under the receiver-operator characteristic
ROC) curve. In all of the previously mentioned models,
hose with an ABI1.4 in 1 or both legs and a normal ABI
n the other leg (if applicable) were excluded due to possible
rterial stiffness and thus the inability to accurately assess
AD (26). Interactions between all traditional and novel
isk factors with ethnicity were examined.
ESULTS
he baseline characteristics of the MESA cohort have been
ublished previously (27). After excluding 161 subjects with
ither an ABI 1.40 or missing data for this variable, 6,653
ubjects remained for this cross-sectional analysis. Overall,
he mean (SD) age was 62.2 (10.2) years, and 52.9% were
omen. Ages ranged from 45 to 85 years with the majority
60%) being between 50 and 69 years. Non-Hispanic whites
ere the largest ethnic group (38%), followed by African
mericans (28%), Hispanics (22%), and Chinese (12%). A
otal of 14% were diabetic, 13% were current smokers, 34%
ad dyslipidemia, and 44% were classified as hypertensive.
The baseline characteristics of the cohort stratified by
BI category are presented in Table 1. Subjects with an
BI 0.90 were significantly older and had higher levels of
ll novel risk factors except von Willebrand factor and titer
ositivity for C. pneumoniae. Furthermore, the proportion
ith diabetes, smoking, hypertension, dyslipidemia, low
ncome ($25,000), and lower education level ( high
chool) were significantly higher in those with PAD.
Table 2 provides the age- and gender-adjusted means and
roportions for the independent variables stratified by eth-
icity. There were significant ethnic differences in all
raditional and novel risk factors. Compared with non-
ispanic whites, African Americans had significantly worse
isk factor levels with the exception of a lower prevalence of
yslipidemia. This included much higher prevalences of biabetes, current smoking, hypertension, less education and
ncome, and higher average values of BMI and the novel
nalytes. Hispanics had worse traditional risk factors com-
ared with non-Hispanic whites, including a higher preva-
ence of dyslipidemia. Conversely, Chinese had the same or
etter average levels of all risk factors compared with whites
ith the exception of a higher prevalence of diabetes, and
ess education and income.
Overall, the prevalence of PAD increased substantially
ith age, such that the rate was 1.3% for those 44 to 49
ears and increased to 9.3% for those over the age of 70.
lthough the mean ABI was significantly lower in women
han in men (1.08 vs. 1.13, p  0.01), the prevalence with
n ABI 0.90 was the same in both genders (4.2 vs. 4.1%,
espectively, p  0.8), a finding that was consistent across
ifferent age categories (44 to 49, 50 to 59, 60 to 69, 70)
nd all ethnic groups. Notably, African Americans had a
ubstantially higher prevalence of PAD (7.2%) compared
ith non-Hispanic whites (3.6%), Hispanics (2.4%), and
hinese (2.0%) (p  0.01 for overall ethnicity association).
here were also differences by diabetes classification. Par-
icipants with diabetes had the highest PAD prevalence
8.7%), whereas the rate was 4.2% in those with impaired
asting glucose and 3.0% for individuals with a normal
asting glucose. For current smokers, PAD prevalence was
.7%; former smokers, 4.4%; and never smokers, 3.0%.
In a multivariable logistic model consisting of age, gen-
er, and ethnicity, each 1-year increment in age was
ssociated with a 10% greater odds of PAD (p  0.01).
here was no significant interaction between gender and
thnicity for PAD. Compared with non-Hispanic whites,
frican Americans were found to have over twice the odds
f an ABI 0.90 (OR  2.28, p  0.01) whereas Chinese
ad significantly lower odds (OR  0.56, p  0.03). The
dds for Hispanics were also lower (OR  0.74), but this
esult was not statistically significant (p  0.14). The area
nder the curve (AUC) associated with the ROC analysis of
his model (age, gender, and ethnicity) was 0.77. The
ddition of diabetes, pack-years of cigarette smoking, hy-
ertension, dyslipidemia, BMI, education, and income lev-
ls increased the AUC to 0.81 (p  0.01, compared with
revious model). Notably, with adjustment for these risk
actors, the ORs were altered for all 3 ethnic groups: African
merican: OR 1.67, Chinese: OR 0.39, and Hispanic:
R  0.49, with all being statistically significant (Table 3).
hen the summary variable for diabetes in the aforemen-
ioned multivariable model was replaced by a variable that
sed 3 categories based on fasting glucose levels, partici-
ants with impaired fasting glucose had an 87% higher odds
f PAD (p  0.02). Similarly, each 1-mU/l increment in
asting serum insulin was associated with a 29% higher odds
or PAD, but the addition of this variable did not improve
he ability of the model to discriminate the presence or
bsence of an ABI 0.90 (AUC  0.81, p  NS).
Table 4 provides the results of adjusted associationsetween novel risk factors and PAD. In general, there was
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September 19, 2006:1190–7 Ethnicity as a Risk Factor for PADdecrease in the magnitude of the OR for PAD for all of
he novel risk factors when adjusted for: 1) age, gender, and
thnicity (“model 1”); then 2) model 1 the traditional risk
actors (“model 2”); and then 3) model 2  the other novel
isk factors (“model 3”). When analyzed individually and
ith adjustment for traditional CVD risk factors, all novel
isk factors were positively associated with PAD except
. pneumoniae (p  0.63) and factor VIII (p  0.58). In a
odel including all novel and traditional risk factors
“model 3”), interleukin and fibrinogen were significantly
ssociated with PAD (p  0.05 for all), whereas homocys-
eine and D-dimer were of borderline significance (0.05 
 0.10). Notably, in a model containing interleukin-6,
-reactive protein, and the traditional risk factors,
nterleukin-6 remained significant, but C-reactive protein
Table 1. Cohort Characteristics and Difference
Traditional Risk Factors
Low A
(n 
Age (yrs) 70
Female gender 149
Ethnicity
Non-Hispanic white 91
Chinese 16
African American 133
Hispanic 35
Diabetes
Normal diabetes status 117
Impaired fasting glucose 77
Untreated diabetes status 18
Treated diabetes status 63
Fasting insulin (mU/l) 7.9
Smoking
Never smoker 99
Former smoker 107
Current smoker 67
BMI (kg/m2) 28.0
Hypertension (yes) 195
Dyslipidemia (yes) 127
Education
High school 65
High school 69
College 111
Grad school 28
Income
$25,000 121
$25,000–$49,999 71
$50,000–$99,999 34
$100,000 or more 21
Novel risk factors
Homocysteine (mol/l) 10.9
C-reactive protein (mg/l) 5.4
Interleukin-6 (pg/ml) 2.1
D-dimer (g/ml) 0.6
Fibrinogen (mg/dl) 383
Plasmin-antiplasmin (nmol/l) 6.0
Factor VIII (%) 181
von Willebrand factor (%) 157
Chlamydia pneumoniae titer positive 221
*Comparing low with normal ankle brachial index (ABI). V
BMI  body mass index.id not. Therefore, in a “final” model adjusted for tradi- oional risk factors and all significant novel risk factors, 1-SD
ncrements in interleukin-6, fibrinogen, D-dimer, and ho-
ocysteine were associated with 32%, 23%, 18%, and 16%
igher odds for PAD, respectively (p  0.05 for all). The
UC for this final model was 0.84 (p  0.01).
With the addition of these novel risk factors, the ORs for
AD by ethnic group remained significantly associated with
AD. Specifically, with adjustment for age, gender, ethnic-
ty, traditional, and novel risk factors, the OR for PAD in
frican Americans decreased to 1.47 (95% confidence
nterval [CI]: 1.07 to 2.02) but remained essentially un-
hanged in Hispanics (OR  0.45, 95% CI: 0.29 to 0.70)
nd Chinese (0.44, 95% CI: 0.24 to 0.78). To facilitate
omparison of the effects of different categories of risk factors
n the ethnicity-specific odds for PAD, Figure 1 provides the
Risk Factors by ABI Category
0.9)
)
Normal ABI (0.91–1.4)
(n  6,378) p Value*
62  10 0.01
) 3,397 (53.3) 0.76
0.01
2,461 (96.4)
780 (98.0)
1,720 (92.8)
1,417 (97.6)
0.01
3,733 (97.0)
1,773 (95.8)
266 (93.7)
582 (90.2)
8 6.8  5.3 0.01
0.01
3,245 (97.0)
2,295 (95.6)
803 (92.3)
5 28.3  5.4 0.28
) 2,747 (43.1) 0.01
) 2,128 (33.5) 0.01
0.01
1,125 (94.5)
1,131 (94.3)
2,937 (96.4)
1,165 (97.7)
0.01
1,879 (93.9)
1,781 (96.2)
1,635 (98.0)
842 (97.8)
4 9.2  3.5 0.01
9 3.7  5.7 0.01
6 1.5  1.2 0.01
9 0.4  0.8 0.01
345  73 0.01
6 4.7  2.1 0.01
163  66 0.01
138  57 0.08
) 4,783 (75.3) 0.06
xpressed as mean  SD or n (%).s in
BI (<
275
 9
(54.2
(3.6)
(2.0)
(7.2)
(2.4)
(3.0)
(4.2)
(6.3)
(9.8)
 9.
(3.0)
(4.4)
(7.7)
 5.
(70.9
(46.2
(5.5)
(5.7)
(3.6)
(2.3)
(6.1)
(3.8)
(2.0)
(2.4)
 4.
 7.
 1.
 0.
 80
 3.
 67
 54
(80.4dds for PAD by ethnicity after adjustment for: 1) age, gender,
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Ethnicity as a Risk Factor for PAD September 19, 2006:1190–7nd ethnic group; 2) model 1  smoking, diabetes, hyperten-
ion, dyslipidemia, BMI, education, and income; and 3) model
 interleukin-6, fibrinogen, D-dimer, and homocysteine.
ISCUSSION
n this large, cross-sectional study of participants from
arying geographic locations and ethnic origins, the relative
dds of PAD, compared with non-Hispanic whites, were
ignificantly elevated in African Americans but were re-
uced in Chinese and Hispanics. Compared with non-
ispanic whites and after adjustment for traditional and
ovel coronary heart disease (CHD) risk factors, African
merican ethnicity was associated with nearly a 50% in-
rease in the odds of PAD. Conversely, Chinese and
ispanic ethnicities were associated with approximately half
he odds for this condition. Importantly, in African Amer-
cans, adjustment for demographic, traditional, and novel
isk factors accounted for an important proportion of the
nadjusted risk. Conversely, after adjustment the inverse
ssociation for Hispanic ethnicity was greatly enhanced and
omewhat enhanced in Chinese. This suggests that eleva-
ions in these risk factors in Hispanics and Chinese made
he overall risk appear to be closer to that of non-Hispanic
hites.
Recent reports from the NHANES have estimated the
verall burden of PAD in the U.S. using ABI criteria at
pproximately 5 million individuals (4.3%) (7,8). In the
HANES, the prevalence of PAD in non-Hispanic whites
as 4.4%. From community-based samples that included
ndividuals under the age of 65, the higher prevalence of
AD in African Americans has been well documented with
nadjusted overall prevalences ranging from 3.3% to 7.9%
Table 2. Age- and Sex-Adjusted Means and P
African America
(n  1,863)
Traditional risk factors
Body mass index (kg/m2) 30.1†
Current smoking (%) 17.0†
Diabetes (%) 19.1†
Dyslipidemia (%) 29.4†
Hypertension (%) 59.5†
Education‡ (%) 69.2†
Gross income $25,000 (%) 65.3†
Novel risk factors
Chamydia pneumoniae titer
positive (%)
81.4†
C-reactive protein (mg/l) 4.8†
D-dimer (g/ml) 0.45†
Factor VIII (%) 177.8†
Fibrinogen (mg/dl) 360.6†
Homocysteine (mol/l) 9.7†
Interleukin-6 (pg/ml) 1.7†
Plasmin-antiplasmin (nmol/l) 5.2†
von Willebrand factor (%) 160.0†
*Reference group; †p value 0.05 compared with non-Hisp7,10,12), which are similar to that found in MESA (7.2%).
totably, prevalence estimates for Hispanics and Asians are
ore limited. Three reports have provided rates in Hispan-
cs (1.8%, 3.0%, and 13.7%) (7,11,12), whereas there is only
study reporting the prevalence in Asians that included
ubjects under the age of 70 years (1.4%) (12). These rates
re all comparable to those found in MESA—Hispanics:
.4% and Asians: 2.0%.
rtions of Risk Factors by Ethnic Group
Chinese
n  798)
Hispanic
(n  1,464)
Non-Hispanic White*
(n  2,528)
24.0† 29.4† 27.8
5.0† 12.0 10.8
14.5† 19.3† 6.7
32.0 38.3† 34.3
35.5 41.6† 36.0
59.4† 33.1† 79.3
50.1† 47.5† 84.2
86.0† 75.6† 69.1
1.9† 4.2† 3.4
0.27† 0.38 0.35
157.6 162.9† 156.5
329.6 360.6† 334.4
8.9† 9.1 9.3
1.1† 1.7† 1.5
4.1† 4.7 4.7
142.9 142.0 137.1
hite; ‡Greater than high school.
able 3. Traditional Risk Factors for PAD
Model #1 Odds Ratio 95% CI
ge (1 yr) 1.10 1.08–1.11
ender (male) 0.99 0.77–1.27
thnicity
Non-Hispanic white 1.00 —
Chinese 0.56 0.32–0.96
African American 2.28 1.72–3.01
Hispanic 0.74 0.50–1.10
Model #2
ge (1 yr) 1.09 1.07–1.11
ender (male) 0.95 0.73–1.23
thnicity
Non-Hispanic white 1.00 —
Chinese 0.39 0.22–0.69
African American 1.67 1.23–2.26
Hispanic 0.49 0.32–0.76
iabetes mellitus 2.12 1.57–2.87
moking 3.42 2.48–4.73
ypertension 1.63 1.22–2.18
yslipidemia 1.58 1.22–2.05
ody mass index 0.97 0.94–0.99
ducation* 0.74 0.55–0.98
ncome† 0.75 0.56–1.01
odel 1: adjusted for age, gender, and ethnicity; model 2: adjusted for age, gender,
thnicity, diabetes, smoking, hypertension, dyslipidemia, body mass index, education,
nd income. *Greater than high school compared with high school or less; †greaterropo
n
(han $25,000 compared with less than this amount.
CI  confidence interval; PAD  peripheral arterial disease.
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September 19, 2006:1190–7 Ethnicity as a Risk Factor for PADSimilar to the findings presented in the preceding text,
fter adjusting for age, gender, smoking, BMI, hyperten-
ion, hypercholesterolemia, diabetes, and kidney function,
frican American subjects from the NHANES had a
ignificantly higher odds (2.39) for PAD than non-Hispanic
hites (7). Conversely, and unlike our MESA results, the
R for Mexican Americans was elevated, but not signifi-
antly (1.15; 95% CI: 0.6 to 2.2). After controlling for
raditional CHD risk factors, a study of university employ-
es reported that African Americans had a significant
.3-fold higher odds of PAD compared with non-Hispanic
hites, whereas Hispanics had 8% higher and Asians a 38%
ower odds, neither of which was statistically significant
12). Finally, in the GENOA (Genetic Epidemiology
etworks of Arteriopathy) study, African Americans were
gain found to be at higher odds for PAD independent of
raditional CHD risk factors. Because these results suggest
hat traditional risk factors did not account for the risk for
AD in different ethnic groups, the authors recommended
identifying additional ‘novel’ risk factors that account for
he ethnic differences in PAD. . .” (28).
igure 1. *Ethnic-specific odds ratios for peripheral arterial disease. *Non-
Table 4. Odds of PAD Associated With a 1-S
Novel Risk Factors
Model
OR (95%
LN homocysteine (mol/l) 1.25 (1.10–
LN C-reactive protein (mg/l) 1.31 (1.15–
LN interleukin-6 (pg/ml) 1.53 (1.34–
LN D-dimer (g/ml) 1.35 (1.19–
Fibrinogen (mg/dl) 1.38 (1.23–
LN plasmin-antiplasmin (nM) 1.29 (1.13–
Percent factor VIII 1.07 (0.95–
C. pneumoniae titer positive (%) 1.04 (0.90–
Model 1: adjusted for age, gender, and ethnicity; model 2: ad
hypertension, body mass index, education, and income; mode
LN  log transformed; OR  odds ratio; other abbreviahinese; HS  Hispanic. Model 1  adjusted for age and gender; model 2
yslipidemia, body mass index, education, and income; model 3  adjusted for tAccordingly, we determined the significance and magnitude
f associations between novel risk factors and PAD. Of the 9
tudied, 4 were significantly associated with PAD after adjust-
ent for age, gender, ethnicity, smoking, diabetes, hyperten-
ion, dyslipidemia, and BMI: interleukin-6, fibrinogen,
-dimer, and homocysteine. Using standardized differences,
-SD increments in interleukin-6 were associated with the
argest odds for PAD (1.32), followed by fibrinogen (1.23),
-dimer (1.18), and homocysteine (1.16). C-reactive pro-
ein, plasmin-antiplasmin, factor VIII, von Willebrand
actor, and a positive antibody titer for C. pneumoniae were
ot significantly associated with PAD. This study also
emonstrated a significant risk factor–adjusted association
or impaired fasting glucose (OR  1.87), as well as fasting
erum insulin (1.29 per 1-SD increment) with PAD.
otably, the addition of the novel risk factors increased the
UC from 0.81 (for traditional risk factors alone) to nearly
.84, indicating some increase in the ability to discriminate
etween those with and without PAD. The inclusion of
ither impaired fasting glucose or serum insulin did not
ncrease the AUC on ROC analysis.
nic white  reference group; †p  0.05. AA  African American; AS 
crement in Each Novel Risk Factor
Model 2 Model 3
OR (95% CI) OR (95% CI)
1.15 (1.02–1.31) 1.13 (0.99–1.30)
1.29 (1.12–1.49) 1.02 (0.85–1.22)
1.47 (1.28–1.70) 1.29 (1.08–1.53)
1.29 (1.12–1.48) 1.15 (0.98–1.34)
1.31 (1.16–1.48) 1.18 (1.01–1.39)
1.29 (1.12–1.47) 1.11 (0.94–1.30)
1.01 (0.88–1.16) 0.96 (0.83–1.09)
1.03 (0.91–1.16) 0.99 (0.86–1.15)
for age, gender, ethnicity, diabetes, smoking, dyslipidemia,
justed for those in model 2 and the other novel risk factors.
as in Table 3.HispaD In
1
CI)
1.41)
1.49)
1.75)
1.54)
1.55)
1.48)
1.21)
1.19)
justed
l 3: ad adjusted for those in model 1  diabetes, smoking, hypertension,
hose in model 2  interleukin-6, fibrinogen, D-dimer, and homocysteine.
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Ethnicity as a Risk Factor for PAD September 19, 2006:1190–7In previous studies, levels of fibrinogen, von Willebrand
actor, and D-dimer have been shown to be higher in
atients with PAD as determined by a low ABI (0.9) (29).
urthermore, studies of different age groups have found
brinogen to be significantly associated with not only
revalent (30) but incident (31) PAD after adjustment for
raditional CHD risk factors, and this increased risk may be
enetically mediated (32). Notably, associations with homo-
ysteine are less consistent (31,33,34). Importantly, there
re insufficient data available in published reports to deter-
ine if there is an interaction between novel risk factors and
thnicity for PAD. We did not observe any such interac-
ions in this study (data not shown).
In MESA, the addition of novel risk factors to a model
djusted for traditional CHD risk factors resulted in a
ubstantial change in the relative odds for PAD among
frican Americans but not in Hispanics and Chinese. Even
fter adjustment for the novel risk factors, ethnicity re-
ained independently associated with PAD, and the mag-
itude of associations are clinically meaningful (i.e., nearly a
0% increased OR for African Americans and approxi-
ately half the odds in Chinese and Hispanics compared
ith non-Hispanic whites). These results suggest that the
ovel risk factors studied do not entirely explain the differ-
nce in ethnic-specific odds for PAD. Therefore, study of
ither additional “novel” risk factors (such as lipoprotein (a)
nd plasminogen activator inhibitor-1) (35) or genetic
arkers of PAD risk are warranted.
Interestingly, in previous studies from this same cohort, the
revalence of coronary calcium is lower in African Americans,
ispanics, and Chinese (27). For African Americans, our
esults contrast with those for the presence of calcium in the
oronary arteries. This suggests that there is either an arterial
ed-specific ethnic atherosclerotic predilection, or that rates of
alcification of atherosclerotic plaques differ by ethnicity.
Our study has limitations, and thus our conclusions are
rawn with caution. First, the selection of subjects, although
opulation-based, was not random and, by design, excluded
ubjects with clinical CVD. Thus, some selection bias was
ossible. Second, the number of cases of PAD in Chinese
nd Hispanics was relatively small. However, the denomi-
ators for these ethnic groups were relatively large, giving
easonable confidence in the low PAD rates in these 2
thnic groups. Finally, residual confounding due to misclas-
ification and non-perfect ascertainment of risk factors
ikely led to an overestimation of the independent effect of
frican-American ethnicity on risk but, by the same token,
ay have led to an underestimation of the independent
ffects of Hispanic and Chinese ethnicity.
onclusions. Traditional and novel CHD risk factors
ccount for some of the differences in the prevalence of
AD in African American, Hispanic, and Chinese ethnici-
ies versus Caucasians. However, the ethnic differences in
he odds of PAD remained significant even after adjustment
or these risk factors. This suggests that either intrinsic risk
actors associated with ethnicity, mediators other than thosetudied, or different durations of risk factor elevations
ccount for the ethnic differences in the odds for PAD.
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